MnO2-Assisted Photosynthetic Bacteria Interfering with the Adenosine-A2AR Metabolic Pathway to Enhance Tumor

Si-Min Zeng1, Wen-Qiang Qu1, Yu-Liang Sun1

  • 1Department of Orthopedic Trauma and Microsurgery of Zhongnan Hospital & Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan 430072, PR China.

ACS Nano
|February 20, 2025
PubMed

Insights

This study developed a manganese dioxide-assisted photosynthetic bacteria biohybrid (MnO2@PSB) to enhance cancer immunotherapy. MnO2@PSB reverses tumor immunosuppression and amplifies anti-tumor immune responses.

Area of Science:

  • Biomedical Engineering
  • Immunology
  • Materials Science

Background:

  • Tumor hypoxia promotes immunosuppression via adenosine (Ado) and A2A receptors (A2AR).
  • Adenosine A2A receptor (A2AR) signaling hinders anti-tumor immunity, particularly following immunogenic cell death (ICD).

Purpose of the Study:

  • To develop a MnO2-assisted photosynthetic bacteria (PSB) biohybrid (MnO2@PSB) for enhanced photothermal immunotherapy.
  • To investigate the interference of MnO2@PSB with the adenosine-A2AR metabolic pathway in tumors.

Main Methods:

  • Conjugation of manganese dioxide (MnO2) nanoflowers onto photosynthetic bacteria (PSB) via carbodiimide reaction.
  • Utilizing MnO2@PSB as a photothermal agent under 808 nm laser irradiation to induce tumor cell ICD.
  • Leveraging MnO2 to catalyze hydrogen peroxide decomposition, alleviating tumor hypoxia and reducing adenosine production.

Main Results:

  • MnO2@PSB treatment induced tumor cell immunogenic cell death (ICD).
  • Alleviation of tumor hypoxia reduced adenosine production and A2AR expression, reversing the immunosuppressive microenvironment.
  • Enhanced anti-tumor immune responses, prolonged survival, and inhibited tumor growth, recurrence, and metastasis in mouse models.

Conclusions:

  • The MnO2@PSB biohybrid effectively enhances photothermal immunotherapy by targeting the adenosine-A2AR metabolic pathway.
  • This approach offers a promising strategy for overcoming tumor immunosuppression and improving therapeutic outcomes.
  • Regulating metabolic pathways presents a viable direction for advancing anti-tumor immunotherapy.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
10.3K